The FDA has approved Tryptyr (acoltremon ophthalmic solution) 0.003% for the treatment of the signs and symptoms of dry eye ...

Ophthalmic pharmaceuticals drive ... There are already generic alternatives for certain forms of Lotemax, and besides the two mentioned drugs, there are a number of other drugs that are set ...

President Donald Trump’s promise to impose tariffs on pharmaceutical imports is raising red flags among generic drugmakers and industry experts, who warn that such a move could lead to increased ...

Ophthalmic pharmaceuticals drive ... There are already generic alternatives for certain forms of Lotemax, and besides the two mentioned drugs, there are a number of other drugs that are set ...

Glenmark Pharmaceuticals Inc., USA announced today the launch of Latanoprost Ophthalmic Solution, 0.005 per cent, a generic version of Upjohn’s Xalatan. This marks the company’s fourth ...

The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s Lotemax. Lupin is the exclusive first-to-file for this product and may be eligible to ...

Loteprednol Etabonate Ophthalmic Gel, 0.38% (RLD Lotemax SM) had an estimated annual sale of USD ... company had received approval from the U.S. FDA for its Abbreviated New Drug Application for ...

According to the company’s statement, the approval has been granted to market a generic equivalent of Lotemax® SM Ophthalmic Gel of Bausch & Lomb Inc. Lupin is the exclusive first-to-file for ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.

Miebo eye drops represent a breakthrough for treating dry eye disease ... However, being a newer brand name drug with exclusive patented technology, Miebo commands a significant price premium compared ...